Taro Shimizu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Human Serum Albumin

Tyrosine Kinase

Cancer Stem Cells

Top Venues

International journal of molecular sciences

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sherif A Gaballa, Taro Shimizu, Haruka Takata, Hidenori Ando, Mohamed Ibrahim, Sherif E Emam, Nana Cristina Amorim Matsuo, Yuri Kim, Youssef W Naguib, Fatma M Mady, Khaled A Khaled, Tatsuhiro Ishida
Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice. Molecular pharmaceutics 21 (2) (2024)
Sherif A Gaballa, Taro Shimizu, Haruka Takata, Hidenori Ando, Mohamed Ibrahim, Sherif E Emam, Nana Cristina Amorim Matsuo, Yuri Kim, Youssef W Naguib, Fatma M Mady, Khaled A Khaled, Tatsuhiro Ishida
Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice. Molecular pharmaceutics 21 (2) (2024)
Sherif A Gaballa, Taro Shimizu, Haruka Takata, Hidenori Ando, Mohamed Ibrahim, Sherif E Emam, Nana Cristina Amorim Matsuo, Yuri Kim, Youssef W Naguib, Fatma M Mady, Khaled A Khaled, Tatsuhiro Ishida
Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice. Molecular pharmaceutics (2024)
Koki Tachibana, Kohshi Kusumoto, Mai Ogawa, Hidenori Ando, Taro Shimizu, Yu Ishima, Tatsuhiro Ishida, Keiichiro Okuhira
FTY720 Reduces Lipid Accumulation by Upregulating ABCA1 through Liver X Receptor and Sphingosine Kinase 2 Signaling in Macrophages. International journal of molecular sciences 23 (23) (2022)
Koki Tachibana, Kohshi Kusumoto, Mai Ogawa, Hidenori Ando, Taro Shimizu, Yu Ishima, Tatsuhiro Ishida, Keiichiro Okuhira
FTY720 Reduces Lipid Accumulation by Upregulating ABCA1 through Liver X Receptor and Sphingosine Kinase 2 Signaling in Macrophages. International journal of molecular sciences 23 (23) (2022)
Koki Tachibana, Kohshi Kusumoto, Mai Ogawa, Hidenori Ando, Taro Shimizu, Yu Ishima, Tatsuhiro Ishida, Keiichiro Okuhira
FTY720 Reduces Lipid Accumulation by Upregulating ABCA1 through Liver X Receptor and Sphingosine Kinase 2 Signaling in Macrophages. International journal of molecular sciences 23 (23) (2022)
Hiroshi Azuma, Toraji Amano, Naoya Kamiyama, Naofumi Takehara, Maki Jingu, Harumi Takagi, Osamu Sugita, Naoko Kobayashi, Tomoko Kure, Taro Shimizu, Tatsuhiro Ishida, Masanori Matsumoto, Hiromi Sakai
First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative. Blood advances 6 (21) (2022)
Koki Tachibana, Kohshi Kusumoto, Mai Ogawa, Hidenori Ando, Taro Shimizu, Yu Ishima, Tatsuhiro Ishida, Keiichiro Okuhira
FTY720 Reduces Lipid Accumulation by Upregulating ABCA1 through Liver X Receptor and Sphingosine Kinase 2 Signaling in Macrophages. International journal of molecular sciences 23 (23) (2022)
Ryo Kinoshita, Yu Ishima, Victor Tuan Giam Chuang, Hiroshi Watanabe, Taro Shimizu, Hidenori Ando, Keiichiro Okuhira, Masaki Otagiri, Tatsuhiro Ishida, Toru Maruyama
The Therapeutic Effect of Human Serum Albumin Dimer-Doxorubicin Complex against Human Pancreatic Tumors. Pharmaceutics 13 (8) (2021)